How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative
- PMID: 21890755
- PMCID: PMC4872501
- DOI: 10.1136/bmjqs-2011-000041
How do centres begin the process to prevent contrast-induced acute kidney injury: a report from a new regional collaborative
Abstract
Objectives: This study evaluates the variation in practice patterns associated with contrast-induced acute kidney injury (CI-AKI) and identifies clinical practices that have been associated with a reduction in CI-AKI. Background CI-AKI is recognised as a complication of invasive cardiovascular procedures and is associated with cardiovascular events, prolonged hospitalisation, end-stage renal disease, and all-cause mortality. Reducing the risk of CI-AKI is a patient safety objective set by the National Quality Forum.
Methods: This study prospectively collected quantitative and qualitative data from 10 centres, which participate in the Northern New England Cardiovascular Disease Study Group PCI Registry. Quantitative data were collected from the PCI Registry. Qualitative data were obtained through clinical team meetings to map care processes related to CI-AKI and focus groups to understand attitudes towards CI-AKI prophylaxis. Fixed and random effects modelling were conducted to test the differences across centres.
Results: Significant variation in rates of CI-AKI were found across 10 medical centres. Both fixed effects and mixed effects logistic regression demonstrated significant variability across centres, even after adjustment for baseline covariates (p<0.001 for both modelling approaches). Patterns were found in reported processes and clinical leadership that were attributable to centres with lower rates of CI-AKI. These included reducing nil by mouth (NPO) time to 4 h prior to case, and standardising volume administration protocols in combination with administering three to four high doses of N-acetylcysteine (1200 mg) for each patient.
Conclusions: These data suggest that clinical leadership and institution-focused efforts to standardise preventive practices can help reduce the incidence of CI-AKI.
Figures
Similar articles
-
Association of Variation in Contrast Volume With Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention.JAMA Cardiol. 2017 Sep 1;2(9):1007-1012. doi: 10.1001/jamacardio.2017.2156. JAMA Cardiol. 2017. PMID: 28678988 Free PMC article.
-
Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.J Invasive Cardiol. 2013 Jun;25(6):276-83. J Invasive Cardiol. 2013. PMID: 23735352 Clinical Trial.
-
Variation in contrast-associated acute kidney injury prophylaxis for percutaneous coronary intervention: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (CART) program.BMC Nephrol. 2020 Apr 28;21(1):150. doi: 10.1186/s12882-020-01802-z. BMC Nephrol. 2020. PMID: 32345254 Free PMC article.
-
Remote Ischemic Conditioning for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions/Coronary Angiography: A Meta-Analysis of Randomized Controlled Trials.J Cardiovasc Pharmacol Ther. 2016 Jan;21(1):53-63. doi: 10.1177/1074248415590197. Epub 2015 Jun 24. J Cardiovasc Pharmacol Ther. 2016. PMID: 26112028 Review.
-
Risk of contrast-induced acute kidney injury in ST-elevation myocardial infarction patients undergoing multi-vessel intervention-meta-analysis of randomized trials and risk prediction modeling study using observational data.Catheter Cardiovasc Interv. 2017 Aug 1;90(2):205-212. doi: 10.1002/ccd.26928. Epub 2017 Jan 23. Catheter Cardiovasc Interv. 2017. PMID: 28112470 Review.
Cited by
-
Management of Patients With Kidney Disease in Need of Cardiovascular Catheterization: A Scientific Workshop Cosponsored by the National Kidney Foundation and the Society for Cardiovascular Angiography and Interventions.J Soc Cardiovasc Angiogr Interv. 2022 Aug 26;1(6):100445. doi: 10.1016/j.jscai.2022.100445. eCollection 2022 Nov-Dec. J Soc Cardiovasc Angiogr Interv. 2022. PMID: 39132354 Free PMC article. Review.
-
Change Management Accompanying Implementation of Decision Support for Prevention of Acute Kidney Injury in Cardiac Catheterization Units: Program Report.Can J Kidney Health Dis. 2023 Oct 18;10:20543581231206127. doi: 10.1177/20543581231206127. eCollection 2023. Can J Kidney Health Dis. 2023. PMID: 37867500 Free PMC article.
-
Incidence, predictors and clinical implications of new renal impairment following percutaneous coronary intervention.Open Heart. 2022 Oct;9(2):e001876. doi: 10.1136/openhrt-2021-001876. Open Heart. 2022. PMID: 36220310 Free PMC article.
-
Effect of Clinical Decision Support With Audit and Feedback on Prevention of Acute Kidney Injury in Patients Undergoing Coronary Angiography: A Randomized Clinical Trial.JAMA. 2022 Sep 6;328(9):839-849. doi: 10.1001/jama.2022.13382. JAMA. 2022. PMID: 36066520 Free PMC article. Clinical Trial.
-
Maintaining a National Acute Kidney Injury Risk Prediction Model to Support Local Quality Benchmarking.Circ Cardiovasc Qual Outcomes. 2022 Aug;15(8):e008635. doi: 10.1161/CIRCOUTCOMES.121.008635. Epub 2022 Aug 12. Circ Cardiovasc Qual Outcomes. 2022. PMID: 35959674 Free PMC article.
References
-
- Bui KL, Horner JD, Herts BR, Einstein DM. Intravenous iodinated contrast agents: risks and problematic situations. Cleveland Clinic journal of medicine. 2007;74:361–4. 7. - PubMed
-
- Tumlin J, Stacul F, Adam A, Becker CR, Davidson C, Lameire N, et al. Pathophysiology of contrast-induced nephropathy. The American journal of cardiology. 2006;98:14K–20K. - PubMed
-
- McCullough PA, Wolyn R, Rocher LL, Levin RN, O’Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368–75. - PubMed
-
- Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–64. - PubMed
-
- Finn WF. The clinical and renal consequences of contrast-induced nephropathy. Nephrol Dial Transplant. 2006;21:i2–10. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous